immatics biotechnologies ...
(IMTXW)
undefined
undefined%
At close: undefined
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -7.91 | 14.58 | -7.82 | -1.85 | -18.38 | -17.1 |
| PS Ratio | 14.21 | 3.16 | 21.39 | 13.56 | 31.62 | 142.60 |
| PB Ratio | 3.41 | 2.57 | 30.90 | 4.06 | -13.94 | -51.66 |
| P/FCF Ratio | -60.28 | 5.82 | -8.5 | -4.55 | 8.49 | 26.64 |
| P/OCF Ratio | 42.10 | 5.46 | -9.09 | -4.95 | 8.22 | 25.99 |
| OCF/S Ratio | 0.34 | 0.58 | -2.35 | -2.74 | 3.85 | 5.49 |
| Debt / Equity Ratio | n/a | n/a | n/a | -0.16 | n/a | n/a |
| Quick Ratio | 2.87 | 3.54 | 1.60 | 3.89 | 1.77 | 2.06 |
| Current Ratio | 2.87 | 3.54 | 1.60 | 3.94 | 1.79 | 2.06 |
| Asset Turnover | 0.11 | 0.42 | 0.20 | 0.12 | 0.14 | 0.06 |
| Interest Coverage | -122.41 | 3.62 | -50 | -241.23 | -194.19 | -2.15K |
| Return on Equity (ROE) | -0.43 | 0.18 | -3.95 | -2.2 | 0.76 | 3.02 |
| Return on Assets (ROA) | -0.19 | 0.09 | -0.54 | -0.9 | -0.24 | -0.51 |
| Return on Capital (ROIC) | -0.29 | 0.10 | -1.09 | -0.36 | -0.51 | -1 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -119.76% | 38.22% | -151.92% | -114.65% | -117.31% | -801.09% |
| Net Profit Margin | -179.63% | 21.71% | -273.45% | -733.84% | -172.05% | -834.06% |
| Pretax Profit Margin | -179.63% | 24.32% | -268.49% | -734.7% | -176.09% | -858.22% |
| Operating Profit Margin | -188.39% | 17.33% | -248.24% | -223.07% | -178.94% | -912.71% |
| FCF Margin | -23.57% | 54.34% | -251.53% | -298% | 372.56% | 535.20% |
| EBITDA Margin | -164.69% | 28.95% | -240.37% | -206.19% | -158.03% | -841.54% |